Effectiveness of Streptococcus Pneumoniae Urinary Antigen Testing in Decreasing Mortality of COVID-19 Co-Infected Patients: A Clinical Investigation.
Antonio DesaiOrazio Giuseppe SantonocitoGiuseppe CaltagironeMaria KoganFederica GhettiIlaria DonadoniFrancesca PorroVictor SavevskiDario PorettiMichele CiccarelliFilippo Martinelli BoneschiAntonio VozaPublished in: Medicina (Kaunas, Lithuania) (2020)
The routine use of Streptococcus pneumoniae u-Ag testing helped to better target antibiotic therapy with a final trend of reduction in mortality of u-Ag+ COVID-19 patients having a concomitant pneumococcal infection. Randomized trials on larger cohorts are necessary in order to draw definitive conclusion.
Keyphrases
- sars cov
- cardiovascular events
- coronavirus disease
- quantum dots
- randomized controlled trial
- risk factors
- systematic review
- highly efficient
- clinical practice
- squamous cell carcinoma
- cardiovascular disease
- stem cells
- visible light
- respiratory syndrome coronavirus
- radiation therapy
- mesenchymal stem cells
- cell therapy